Company Overview and News

 
China’s stocks fall to 4-year low amid fears of forced selling

2018-10-18 scmp
Benchmark gauge closes at lowest since November 2014 as fears grow that shares pledged as collateral will face forced sales, fuelling further losses
SCHYF WYNMF HSNGF HCS 0011 1128 HSB 0005 HSNGY HSEA 1928 HSEB SCHYY HSBC WYNMY HBCYF

 
Macau casino shares down 40 per cent since June as trade war deters Chinese high rollers

2018-10-16 scmp
China’s crackdown on corruption and investors’ fears over the impact of the trade war on the economy have sent the stock prices of Macau’s top six casinos tumbling an average of 40 per cent since June, bringing their valuations back down to reasonable levels.
SCHYF WYNMF 0200 0880 SJMHY MDEVF 1128 506186 GLXYENT 1928 MS SJMHF SCHYY WYNMY

 
IPO Update: Studio City International Finalizes U.S. IPO Terms

2018-10-14 seekingalpha
The IPO is pricey, MSC has significant debt and customer demand uncertainties lie ahead due to an ongoing trade war between the U.S. and China.
1128 WYNMF WYNMY

 
Macau casinos golden week run seen fading as China economy slows

2018-10-08 theedgemarkets
(Oct 8): Macau’s robust Golden Week holiday performance isn’t likely to continue with concerns over China’s softening economy weighing down the gambling outlook in the world’s biggest gaming center.
WYNMF GXYEF GXYYY 1128 0027 MS WYNMY

 
Hong Kong stocks fall to two-week closing low on lingering economic growth fear

2018-10-03 scmp
Hong Kong stocks extended losses on Wednesday to close at their lowest in two weeks, tracking declines in the US and as investors remained cautious in the wake of China’s slowing economy that could be squeezed further in the prolonged trade war with the US.
STAN 55BC SCHYF WYNMF GXYEF CBQS GXYYY AAIGF 1128 0027 580001 STAB STAN STAC 2888 SCBFF 1928 AAGIY SCHYY WYNMY

185
Stocks To Watch: Strap In For Q4

2018-09-29 seekingalpha - 3
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
STZ.B SGMS PRTK PLYA BHC 1128 LADR HCA NWN 1928 MTOR WELL AET BGS TSO AMC ARNC PSA MDT CXW OZK MTH CZR CPS SPG FCAU ADS IGT TM LEN CONN WCG FIZZ MPC SJMHY MLCO MOH MZOR YRCW LUV KBH WYNMF HMC 0880 HAS TSLA CRY HLT RPM BYD WYNMY CNC TWX HA SKYW SEM PSA.A CVS LEAF OMF SUI CALM BKS ALGT BCO STAY AAL ADNT WTW STZ NAV MAT UAL BRX ERI PENN ATHN SJMHF DAN JBLU SFIX PIR ANDV ALK CVGW PSAXZ GM DAL PAYX F TRUP CMCSA KPTI COST SCHYF GLPI 506186 PEP GLXYENT ABG THC SCHYY PZZA

 
Hong Kong stocks snap six-day losing streak as prospect of fresh US-China trade talks boosts sentiment

2018-09-26 scmp
China and Hong Kong stocks rose for the first time this week after the Trump administration proposed a new round of trade talks, raising optimism of a detente in the ongoing trade war between the world’s two largest economies.
SOTGY HSNGF 0011 1128 HSB HSNGY 1928 CICHF HSBC CCB 0939 HBCYF SCHYF WYNMF 2382 GXYEF HCS GXYYY SNPTF AACAF CICHY 0005 0027 0700 HSEA HSEB SCHYY AACAY WYNMY

 
Macau casinos reopen with US$186 million loss as gamblers stayed away during Typhoon Mangkhut’s onslaught

2018-09-26 scmp
Macau casino stocks retreated after Typhoon Mangkhut forced a 33-hour shutdown of the world’s biggest gambling hub, a halt that’s estimated to cost operators including Sands China and Wynn Macau as much as US$186 million in revenue.
DB SCHYF WYNMF GXYEF GXYYY 0880 SJMHY 1128 0027 1928 MS SJMHF SCHYY WYNMY

 
Macau casinos to reopen after brief, if costly, typhoon shutdown

2018-09-17 thestar.com.my
HONG KONG: Macau, the world’s largest gambling hub, will resume gaming Monday at all its casinos after Typhoon Mangkhut forced a 33-hour shutdown of resorts including Sands China Ltd. and Wynn Macau Ltd. that’s estimated to cost operators as much as $186 million in revenue. Casinos will reopen at 8 a.m. Monday, the government said in a statement, after being closed at 11 p.m. Saturday with the storm approaching.
2282 DB SCHYF WYNMF MCHVF 0880 SJMHY 1128 MCHVY 1928 MS SJMHF SCHYY WYNMY

4
China Slowdown Creates an Opportunity in Gambling Stocks

2018-09-14 investorplace
Much of the recent decline in Chinese equities centers around gambling stocks. With China feeling the effects of a trade dispute, its stocks have fallen. Now, fears of fewer customers in Chinese casinos have reached a fever pitch. Although nobody knows what will happen with Chinese gambling stocks in the near term, investors have options to profit from this looming slowdown.
1128 MGM 0027 WYNN SCHYF 1928 WYNMF LVS GXYEF GXYYY SCHYY WYNMY

6
Caesars: A Misunderstood Bankruptcy Reorg With 100%+ Upside

2018-09-12 seekingalpha
Investors appear to be underappreciative of Caesars’ growth playbook through sale-leaseback arbitrage transactions with VICI (REIT), while at the same time acquiring incremental properties and implementing property level improvements through Total Rewards.
1128 WYNN CZR PNK CACQ PENN WYNMF VICI BYD WYNMY

4
4 Casino Stocks That Are Roaring Higher

2018-09-05 investorplace
As goes Macau, so goes casino stocks. That has been the trend this decade for casinos with any exposure to Macau, which is considered by many to be Asia’s far-bigger version of Las Vegas. When things in Macau are going well, casino stocks are in rally mode. When things in Macau aren’t going well, casino stocks struggle.
1128 MGM MLCO WYNN WYNMF LVS WYNMY

2
Why Is Wynn (WYNN) Down 0.7% Since Last Earnings Report?

2018-08-31 zacks
A month has gone by since the last earnings report for Wynn Resorts (WYNN - Free Report) . Shares have lost about 0.7% in that time frame, underperforming the S&P 500.
1128 WYNN WYNMF WYNMY

2
Wall St. set to open higher on US-China trade talks - Channel NewsAsia

2018-08-20 channelnewsasia
U.S. stock index futures rose on Monday on hopes that planned trade talks between the United States and China would help resolve escalating trade tensions between the world's two largest economies.
1128 WYNN WYNMF WYNMY

2
Wall St. set to open higher on U.S.-China trade talks

2018-08-20 reuters
(Reuters) - U.S. stock index futures pointed to a higher open on Monday as reports of planned trade talks between the United States and China raised hopes of a potential resolution to their trade row.
1128 WYNN WYNMF WYNMY

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...